External Ventricular Drain Market Size, Share, and Trends 2026 to 2035

Revenue, 2025

USD 7.77 Bn

Forecast Year, 2035

USD 13.47 Bn

CAGR, 2026 - 2035

5.66%

Report Coverage

Global

What is the External Ventricular Drain Market Size?

The global external ventricular drain market size was calculated at USD 7.77 billion in 2025 and is predicted to increase from USD 8.23 billion in 2026 to approximately USD 13.47 billion by 2035, expanding at a CAGR of 5.66% from 2026 to 2035.

External Ventricular Drain Market Key Takeaways

• North America led the global market with the highest market share in 2025.
• The Traumatic Brain Injury (TBI) segment took the lead as the foremost market stake in reported cases in 2025.

Major Trends in the External Ventricular Drain Industry

An external ventricular drain (EVD) is employed for the drainage of CSF (cerebrospinal fluid) from the brain ventricles. The ventricular drainage arrangements are used to release elevated ICP (intracranial pressure), drain blood post hemorrhages, trench the infected cerebrospinal fluid, distract the stream of cerebrospinal liquid, and supervise the intracranial stress. A ventricular drainage apparatus contains an exterior drainage arrangement linked to ventricular catheter. The arrangement comprises numerous components like an ant reflux gathering chamber, access port, pressure scale, and drainage bag. It is typically inserted in the operation theatre by a brain surgeon, and the process is carried out with general anesthesia.

Over the recent past, the incidence of hydrocephalus has augmented significantly, enhancing the demand for EVD (external ventricular drain) as a procedure of treatment. The high incidence of hydrocephalus and the rising geriatric population are major aspects that are anticipated to drive the market progress over the forecast time-duration. The rising healthcare market in emerging economies is also anticipated to provide development opportunities for the external ventricular drain industry over the forecast duration.

The increasing prevalence of hydrocephalus is one of the major driving factors for the growth of global external ventricular drain market. Hydrocephalus is an atypical build-up of liquid in the ventricles (cavities) deep inside the brain. This surplus fluid induces the ventricles to broaden, putting stress on the tissues of the brain. Cerebrospinal fluid (CSF) is the colorless, clear fluid that shields and cushions the spine and brain. Usually, cerebrospinal fluid tides through the ventricles and rinses the spinal cord and brain before getting resorbed into the blood flow. The body stereotypically produces adequate CSF every day and engrosses the same quantity. Nevertheless, when the regular flow or assimilation of CSF is jammed it can lead to an aggregation of CSF. The stress from excessive CSF can restrain the brain from operating properly and induce brain damage and even demise. As per the Hydrocephalus Association, around 1 million individuals in the U.S. are affected by hydrocephalus, in each stage of lifetime, from newborns to the aged. Hydrocephalus can be extremely grave, and even lethal if left untreated. Around 50% of individuals who don't undergo treatment for hydrocephalus die. While, the other half live with what is termed arrested hydrocephalus.

External Ventricular Drain Market Growth Factors

• Growing incidence of neurological diseases
• Growing focus on research and development in the field of neuro care
• Rising number of traumatic brain injuries due to road accidents
• Fast adoption of latest healthcare technology globally
• Growing number of cranial injuries
• Growing demand for less invasive neurosurgical procedures
• Multiple advantages offered by external ventricular drain procedures
• Rising awareness related to neurological disorders in low-income countries

Market Scope

Segment Insights

Indication Insights

Traumatic Brain Injury (TBI) Segment Reported Foremost Market Stake in 2025

The traumatic brain injury (TBI) displayed the major share in the worldwide external ventricular drain market in 2025. Increasing number of accidents leading to brain injuries is the key reason for highest market stake of software segment. The factors, such as increasing number of sports injuries and technological advancements are expected to retain the dominance of software in the near future.

The meningitis segment is anticipated grow at the maximum CAGR through the forecast time-frame mainly due to high anticipated demand.

End-User Insights

Hospitals Dominated the Market Revenue By End-User

High preference is given to hospitals for carrying out complex neurosurgical procedures. Moreover, hospitals are equipped with the latest equipment required for advanced procedures.

Regional Insights

U.S. External Ventricular Drain Market Size and Growth 2026 To 2035

The U.S. external ventricular drain market size was valued at USD 1.80 billion in 2025 and is expected to be worth USD 3.13 billion by 2035, at a CAGR of 5.69% from 2026 to 2035.

North America is Estimated to be the Largest Market for External Ventricular Drain

The detailed research report covers significant prospects and inclinations of external ventricular drain products throughout different regions including Europe, North America, Asia-Pacific, Africa, Middle East, and Latin America. By region, external ventricular drain market is led by North America due to early adoption of advanced healthcare technologies and availability of state-of-the-art healthcare infrastructure. Europe reported the second maximum share predominantly due to presence of key industry players and increasing geriatric population. Asia-Pacific is also anticipated to witness the rapid growth rate, on account of increasing investment by major manufacturers and high number of accidents.

Value Chain Analysis

• Research and Development: Conducts research, design, and development of new types of EVDs or products aimed at improving the existing ones.

Key Players: Medtronic, Integra LifeSciences, and Spiegelberg GmbH

• Clinical Trials and Regulatory Approvals: Encompasses all testing conducted with EVDs on human patients to determine safety and efficacy, and then obtaining the corresponding regulatory approvals to enter the market.

Key Players: U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA)

• Formulation and Final Dosage Preparation: Usually related to the preparation of medicinal products, but for medical devices such as EVDs, it refers to the design, choice of materials, and manufacturing process of the device to meet required specifications or standards, ready for use.

Key Players: Medtronic, Integra LifeSciences, and Spiegelberg GmbH

• Packaging and Serialization: These steps are concerned with the packaging of EVDs to keep them safe during storage and transit and to imprint or assign unique identifiers onto each product to help trace and avoid counterfeiting.
• Distribution to Hospitals and Pharmacies: This consists of all activities involved in the transport and delivery of EVDs toward health- and medical-care-related establishments that would employ EVDs in hospitals and specialty clinics.

Key Players: Cardinal Health, Owens & Minor, and McKesson

• Patient Support and Services for the External Ventricular Drain: Refers to the continuous follow-up, care, and management of EVD patients, including troubleshooting, dressing changes, and neurological assessments.

Key Players: Cardinal Health

External Ventricular Drain Market Companies

The companies focusing on research and development are expected to lead the global external ventricular drain market. Leading competitors contending in global external ventricular drain market are as follows:

• Medtronic
• Integra LifeSciences Corporation
• Spiegelberg
• Sophysa
• Möller Medical
• Fugi Systems Corporation

In order to well recognize the present status of external ventricular drain, and policies implemented by the foremost nations, Precedence Research projected the future progress of the external ventricular drain market. This research report bids quantitative and qualitative insights on external ventricular drain market and valuation of market size and progress trend for probable market segments.

Major Market Segments Covered

By Indication

• Traumatic Brain Injury (TBI)
• Subarachnoid Hemorrhage into CSF
• Meningitis
• Posterior Fossa Tumor
• Subdural Hematoma (SDH)
• Hematomas Posterior Fossa
• IV Ventricle Obstruction
• Others

By End-User

• Hospitals
• Pediatric Care Center
• Ambulatory Surgery Centers
• Others

By Region

• North America
  • • U.S.
    • Canada
• Europe
  • • Germany
    • France
    • United Kingdom
    • Rest of Europe
• Asia Pacific
  • • China
    • Japan
    • India
    • Southeast Asia
    • Rest of Asia Pacific
• Latin America
  • • Brazil
    • Rest of Latin America
• Middle East & Africa (MEA)
  • • GCC
    • North Africa
    • South Africa
    • Rest of Middle East & Africa